Sermorelin
£34.99
Sermorelin is the amidated 29-amino-acid GHRH(1-29) fragment, supplied as above 99% HPLC-verified lyophilised material for laboratory research. For laboratory, analytical and scientific research only. Not for human or veterinary use.
Out of stock
LOT AND COA STATUS
Sermorelin 10mg lot ZC0030 is live. Its independent Certificate of Analysis is currently pending and will be added when received.
- Lot reference
- ZC0030
- Product size
- 10mg
- COA status
- Pending
No purity or analytical result is claimed until the independent report has been received and published.
Description
For Research Use Only. This product is supplied exclusively for laboratory research and is not intended for human or veterinary use.
Sermorelin GHRH(1-29)-NH2 Research Peptide
Sermorelin is the C-terminally amidated 29-amino-acid fragment of human growth hormone-releasing hormone, commonly written as GHRH(1-29)-NH2 or GRF(1-29) amide. This region retains full GHRH-receptor agonist activity in experimental systems.
It is used in receptor, pituitary-cell and somatotropic-axis research. This product is not presented as a medicine, diagnostic agent or human-use preparation.
Technical Specifications
| Product | Sermorelin |
|---|---|
| Peptide length | 29 amino acids |
| Identity | Human GHRH(1-29)-NH2 / GRF(1-29) amide |
| Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Molecular weight | Approximately 3357.9 g/mol |
| Primary receptor | GHRH receptor |
| Purity | Above 99% by third-party HPLC testing |
| Physical form | Lyophilised research material |
| Available formats | 10mg |
| Intended use | Laboratory research and analytical use only |
Independent Batch Testing
Every current ZENTRA Sermorelin batch is independently tested and records an HPLC purity result above 99%. Use the batch number printed on the product label to locate the corresponding third-party report in our Batch Verification and COA Centre. Researchers should consult the individual report for the exact analytical methods, result and testing date for their supplied batch.
Sermorelin Research Context
Published studies established that GHRH(1-29)-NH2 can activate the GHRH receptor and stimulate growth-hormone release in controlled research settings. It has also been investigated as a pharmacological probe of pituitary reserve.
Those findings concern regulated study material and defined protocols. They do not establish a self-use application for this research product.
Storage and Handling
Keep unopened lyophilised material at approximately -20°C for long-term storage or 2-8°C for short-term laboratory storage. Protect from light, moisture and repeated temperature changes.
Sermorelin Research FAQs
What is Sermorelin?
Sermorelin is the amidated first 29 amino acids of human GHRH.
Why is it written GHRH(1-29)-NH2?
The notation identifies residues 1-29 of GHRH and the amide group at the C-terminus.
Is Sermorelin the same as Tesamorelin?
No. Tesamorelin is a modified 44-amino-acid GHRH analogue; Sermorelin is the shorter 1-29 amide fragment.
What receptor does it activate?
Published research characterises it as a GHRH-receptor agonist.
How is purity checked?
The current batch is independently HPLC tested above 99% and linked to an online report.
Is this for human or veterinary use?
No. It is supplied strictly for laboratory research.
Selected Scientific Sources
- GHRH(1-29)-NH2 and a D-Ala2 analogue in normal men.
- Responses to analogues of growth hormone-releasing hormone.
- Sermorelin: a review of its use in diagnosis and treatment research.
Research Resources
- Tesamorelin Research Peptide
- CJC-1295 without DAC
- Batch Verification and COAs
- Research Compound Storage Guide
- Browse All Research Peptides
For research use only. Not for human or veterinary use.
Additional information
| Size | 10mg |
|---|





Reviews
There are no reviews yet.